Morepen Laboratories Limited (NSE:MOREPENLAB)

Market Cap	29.83B
Revenue (ttm)	17.84B
Net Income (ttm)	1.26B
Shares Out	n/a
EPS (ttm)	2.40
PE Ratio	23.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	988,279
Average Volume	6,048,880
Open	54.50
Previous Close	54.52
Day's Range	54.23 - 55.14
52-Week Range	42.00 - 100.90
Beta	1.45
RSI	59.89
Earnings Date	May 5, 2025

About Morepen Laboratories

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermome...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 2,152
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MOREPENLAB

Financial Performance

In 2023, Morepen Laboratories's revenue was 17.02 billion, an increase of 19.68% compared to the previous year's 14.22 billion. Earnings were 961.60 million, an increase of 148.63%.